These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
109 related articles for article (PubMed ID: 6085167)
1. [Interferon]. Smogorzewska E Probl Med Wieku Rozwoj; 1984; 13():176-84. PubMed ID: 6085167 [TBL] [Abstract][Full Text] [Related]
2. Human fibroblast interferon in treatment of viral diseases of the skin and mucous membranes. Isacsohn M; Berson B; Sternberg I; Morag A Isr J Med Sci; 1983 Nov; 19(11):959-62. PubMed ID: 6319325 [TBL] [Abstract][Full Text] [Related]
3. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts). Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976 [TBL] [Abstract][Full Text] [Related]
4. [Interferon in the treatment of viral, neoplastic and immunologic diseases]. Inglot AD Patol Pol; 1984; 35(3):245-61. PubMed ID: 6085509 [No Abstract] [Full Text] [Related]
5. [Update on the use of interferons in clinical practice]. Lauta VM Clin Ter; 1995; 146(6-7):393-448. PubMed ID: 7586995 [TBL] [Abstract][Full Text] [Related]
6. Comparative in vivo and in vitro activation of human natural killer cells by two recombinant alpha-interferons differing in antiviral activity. Edwards BS; Hawkins MJ; Borden EC Cancer Res; 1984 Jul; 44(7):3135-9. PubMed ID: 6586292 [TBL] [Abstract][Full Text] [Related]
7. [Interferon in skin diseases]. Niimura M Gan To Kagaku Ryoho; 1984 Feb; 11(2):221-6. PubMed ID: 6364993 [TBL] [Abstract][Full Text] [Related]
8. [Interferon--properties and action]. Zamorska I; Kozłowski M Wiad Lek; 1989 Oct 1-Nov 1; 42(19-21):1086-91. PubMed ID: 2517808 [TBL] [Abstract][Full Text] [Related]
10. [Antitumor effect of interferons]. Ebina T; Saito M Gan To Kagaku Ryoho; 1984 Jan; 11(1):24-35. PubMed ID: 6421241 [TBL] [Abstract][Full Text] [Related]
11. Inborn errors of interferon (IFN)-mediated immunity in humans: insights into the respective roles of IFN-alpha/beta, IFN-gamma, and IFN-lambda in host defense. Zhang SY; Boisson-Dupuis S; Chapgier A; Yang K; Bustamante J; Puel A; Picard C; Abel L; Jouanguy E; Casanova JL Immunol Rev; 2008 Dec; 226():29-40. PubMed ID: 19161414 [TBL] [Abstract][Full Text] [Related]
12. Immune selection in murine tumors. Ph.d thesis. Svane IM; Engel AM APMIS Suppl; 2003; (106):1-46. PubMed ID: 12739251 [TBL] [Abstract][Full Text] [Related]
13. NK cell receptors as tools in cancer immunotherapy. Sentman CL; Barber MA; Barber A; Zhang T Adv Cancer Res; 2006; 95():249-92. PubMed ID: 16860660 [TBL] [Abstract][Full Text] [Related]
14. Natural killer cell activity in patients with multiple sclerosis given alpha interferon. Rice GP; Casali P; Merigan TC; Oldstone MB Ann Neurol; 1983 Sep; 14(3):333-8. PubMed ID: 6638954 [TBL] [Abstract][Full Text] [Related]
15. Differences in natural and recombinant interferon for herpes keratitis in two animal models. Sanitato JJ; Varnell ED; Kaufman HE; Raju VK Invest Ophthalmol Vis Sci; 1984 Jul; 25(7):874-6. PubMed ID: 6735652 [TBL] [Abstract][Full Text] [Related]
16. Severe herpes virus (HSV-2) infection in two patients with myelodysplasia and undetectable NK cells and plasmacytoid dendritic cells in the blood. Dalloul A; Oksenhendler E; Chosidow O; Ribaud P; Carcelain G; Louvet S; Massip P; Lebon P; Autran B J Clin Virol; 2004 Aug; 30(4):329-36. PubMed ID: 15163423 [TBL] [Abstract][Full Text] [Related]